bioMérieux
Biotechnology ResearchView the employees at
bioMérieux-
Victoire Lessoré de Sainte Foy Chef de projet Third Partie Products en alternance chez bioMérieux
-
Greater Lyon Area
-
Rising Star
Huguet Catherine Assistante de Direction chez bioMerieux-
Greater Lyon Area
-
Rising Star
Julien Thao My Regulatory affairs specialist chez bioMerieux-
Greater Lyon Area
-
Rising Star
Hannah Louise Landicho Associate Scientist at bioMérieux-
Salt Lake City, Utah, United States
-
Rising Star
Magdalena Szewczyk Passionate HR leader/ people and culture/change management/trainer-
Warsaw, Mazowieckie, Poland
-
Rising Star
Overview
Pioneering Diagnostics A world leader in the field of in vitro diagnostics for 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the Euronext Paris stock market. Symbol: BIM – ISIN Code: FR0013280286 Reuters: BIOX.PA/Bloomberg: BIM.FP
-